Video & Transcript DataContr Research : 'pharmaceutical pricing'

Page 1 of 27
US
Transcript Highlights:
  • for people who need it most, the patients and consumers who can't afford to keep paying sky-high prices
  • At the mercy of drug companies that can keep prices high
  • That competition leads to better prices.
  • 121" data-time="1440"> But they try to accomplish the same goal of making PBMs' operations in the pricing
  • in the phone calls about people wanting us to take legislation up that will get prescription drug prices
Summary: The meeting focused on addressing the high cost of prescription drugs and the abusive practices that contribute to elevated prices affecting American families. Several bills were presented, including proposals to end pay-for-delay deals and to enhance transparency in the operations of pharmacy benefit managers (PBMs). The discussion was notable for its emphasis on consumer protection and ensuring that cheaper generic drugs reach the market more effectively. Members expressed frustration over past attempts to pass similar legislation stalling in the Senate, leading to renewed efforts to push these bills forward.
TX

Texas 2025 - 89th Regular

Delivery of Government Efficiency May 7th, 2025 at 10:05 am

House Delivery of Government Efficiency Committee

Transcript Highlights:
  • A bundled pricing program is important for several reasons.
  • This way, you have the total price for the same type of service.
  • If that price is lower than what we are currently paying...
  • All that would be in that price.
  • I have worked on healthcare pricing since I've been here, but...
Summary: The meeting of the committee was characterized by a vigorous discussion surrounding several key bills, particularly with an emphasis on artificial intelligence regulation and healthcare. Senator Parker introduced SB1964, aimed at establishing ethical guidelines and oversight for AI systems used in Texas government, which drew significant support from various stakeholders including the AI Innovation Association. Additionally, there was a push for transparency in governmental processes as exemplified by discussions on HB1225, which seeks to implement bundling pricing for surgical procedures to enhance financial predictability for state employees. The committee witnessed multiple testimonies from industry experts stressing the importance of these measures in safeguarding public interest while fostering innovation. The atmosphere was collaborative, with representatives expressing genuine enthusiasm for prospective amendments to further refine the legislation.
TX

Texas 2025 - 89th Regular

Health and Human Services May 13th, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • House Bill 1612 addresses hospital pricing disparities.
  • What's the price?
  • Hiding prices, conversely, allows for bad conduct, frankly.
  • As a result, high-cost prices went down.
  • and market pressure pushing those prices down.
Summary: The committee meeting centered on several significant bills regarding public health and safety, particularly focusing on healthcare access, transparency, and opioid crisis response. Notably, House Bill 4783 sparked considerable discussion as it aims to enhance the state's approach to prevent opioid overdoses by directing the Health and Human Services Commission (HHSC) to prepare biannual reports on opiate antagonist programs. The testimony from public officials like Dallas City Council's Paula Blackman, who spoke passionately about the ongoing fentanyl epidemic, highlighted the urgent necessity of improved access to life-saving medications. In addition, House Bill 1314 drew attention for addressing hospital pricing transparency, attempting to ease financial burdens on patients by mandating accurate upfront estimates for healthcare costs.
US
Transcript Highlights:
  • span marker="137" data-time="1632">Not only has the federal government not effectively regulated the price
  • 139" data-time="1656"> ...under the Biden administration in terms of negotiating prescription drug prices
  • the money, they say thank you very much, and they go out and charge the American people sky-high prices
  • marker="141" data-time="1680">In 2023, this committee released a report that found that the average price
  • industry, and use every tool at his or her disposal to substantially lower the outrageous prices of
Summary: The meeting focused on vital health-related nominations, primarily emphasizing the roles of Dr. Jay Bhattacharya for NIH Director and Dr. Monty McCary for FDA Commissioner. During the discussion, various senators expressed their support and concerns regarding these nominations. Senator Sanders voiced opposition to both candidates, highlighting issues related to drug affordability and public trust in health agencies. He emphasized the need for leaders committed to transparency and addressing the epidemic of high prescription drug prices, advocating for action against pharmaceutical industry greed. Overall, the conversation underscored the critical crossroads in public health leadership amidst ongoing challenges such as trust restoration and healthcare accessibility.
TX

Texas 2025 - 89th Regular

Business and Commerce (Part II) May 1st, 2025

Senate Business & Commerce Committee

Transcript Highlights:
  • A buyer may pay the advertised cash sale price offered at
  • It also adds language that prohibits the retail seller from adding fees to the sales price.
  • They do, and again, the price of a vehicle—your first...
  • They said, "Oh, no, no; the price would be much higher if it's that."
  • not the price.
Summary: The committee meeting focused heavily on the discussion surrounding HB149, an act aimed at establishing a comprehensive framework for the regulation of artificial intelligence (AI) in Texas. The bill seeks to ensure that AI technologies are developed and deployed in a manner that is both innovative and responsible, addressing potential harms while protecting individual rights and privacy. Chairman Schwartner led the conversations, emphasizing the importance of balancing regulatory measures with the need for technological advancement. Several stakeholders, including legal experts and industry representatives, provided testimony in support of the bill, praising its potential to position Texas as a leader in AI governance. Public testimony reflected a mixture of support and caution, with some witnesses advocating for greater accountability and regulatory oversight to mitigate risks associated with AI systems.
TX

Texas 2025 - 89th Regular

Business and Commerce (Part I) May 1st, 2025

Senate Business & Commerce Committee

Transcript Highlights:
  • My Puppy Dreams retains an attorney that contacted me to refund my purchase price or exchange the puppy
  • even have an APR, and so this provision leaves open the possibility of caps on factor rates or other pricing
Summary: In the recent meeting of the Senate Committee on Business and Commerce, multiple significant bills were discussed, with House Bill 912 and Senate Bill 1003 receiving favorable recommendations for further consideration. Senator Zaffirini played a pivotal role in moving several bills through the committee process, including Senate Bill 748, which also received support with a unanimous vote. Public testimonies were taken for various bills, notably SB 2113, which focuses on improving legislative access to information, fostering a more transparent government. The committee's discussions were marked by an emphasis on good governance and the importance of legislative oversight.
TX

Texas 2025 - 89th Regular

Health and Human Services Apr 2nd, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • We have to find a way to get better prices and make this work for all of America.
  • In 2023, three-fifths, or three out of five Texans delayed care because of healthcare prices.
  • This effectively inhibits shopping by requiring rate and price disclosures and requiring health plans
  • That's all going to have to be priced into the plan.
  • Surgical centers, you know, we've heard a lot of different ways, cash prices, things like this.
Summary: The Senate Committee on Health and Human Services convened to discuss several significant bills, including SB968, SB966, and SB437. Senator Zaffirini presented SB968, which aims to modernize podiatry regulations in alignment with current practices, while SB966 involves the licensing and regulation of podiatry, addressing outdated provisions following a 2017 transition to the Texas Department of Licensing and Regulation. Both bills indicate a necessary clean-up of statutory language to better reflect contemporary standards in healthcare regulations. Additionally, Senator Hinojosa proposed SB437, which focuses on providing effective regulatory frameworks for chemical dependency treatment facilities, highlighting an urgent increase in demand due to rising substance abuse rates post-COVID-19.
TX

Texas 2025 - 89th Regular

Health and Human Services Apr 1st, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • cash prices that were both well below what a nearby hospital would charge, and the cash price was often
  • for price gouging and leads to extra...
  • There's a negotiated price that's set, yet they still tried to charge me an extra price.
  • and so forth, finding our cash prices...
  • Prices vary wildly, and a patient doesn't have a real reason to care once the price is over their deductible
Summary: The meeting centered on multiple significant legislative proposals aimed at healthcare reforms, notably focused on the operations of pharmacy benefit managers (PBMs) and their impact on local pharmacies. Senator Hughes led the discussion on SB1236, which aims to regulate PBMs to prevent anti-competitive practices that have led to the closure of numerous community pharmacies. Testimonies from various stakeholders, including pharmacists, highlighted the challenges posed by current PBM practices, such as aggressive audit tactics and contract terms that disadvantage small pharmacies. The bill was generally supported in the committee due to its potential to restore balance and fairness in pharmacy operations.
TX

Texas 2025 - 89th Regular

State Affairs Apr 30th, 2025 at 10:04 am

House State Affairs Committee

Transcript Highlights:
  • If the prices don't go up enough, then the future producers don't necessarily appreciate that quality
Summary: During this meeting, various important bills were discussed, including HB5573, which aims to provide whistleblower protections for public employees reporting wasteful government spending. Representative Bojani emphasized the need to encourage ethical governance and transparency in government operations. The committee adopted a key amendment to enhance protections against retaliatory actions towards these whistleblowers, highlighting a commitment to fostering accountability within the government. Additionally, HB5623 and HB4921 were moved forward with favorable reports, focusing on energy efficiency projects and the prohibition of state funds benefiting companies that outsource jobs, respectively, reflecting concerns about job retention in Texas.
TX

Texas 2025 - 89th Regular

State Affairs Apr 30th, 2025 at 08:04 am

House State Affairs Committee

Transcript Highlights:
  • They're much lower in price and much more affordable, while everything else in the grid is becoming more
Summary: The committee meeting covered a wide range of bills, highlighting legislative efforts to address energy efficiency, border security, and public safety. Notably, the discussions surrounding HB3824 focused on establishing fire safety standards for battery energy storage systems, inciting concerns about their proximity to schools and hospitals. Members expressed varying opinions on the technology while considering public safety and infrastructure requirements. The meeting also saw the passage of multiple bills, including HB1554, which prohibits the use of public funds for legal services for unlawfully present individuals, showcasing a strong political consensus on border-related issues. Overall, the session was marked by substantial public engagement and the intent to address critical legislative priorities effectively.
TX

Texas 2025 - 89th Regular

Public Health Apr 21st, 2025 at 12:04 pm

House Public Health Committee

Transcript Highlights:
  • Plain-language description and the prices on that statement
  • This bill relates to the Texas Pharmaceutical Initiative.
  • The evidence on consolidation in healthcare is clear: it means higher prices, and it means no change
  • have experienced a 30% reduction in compensation compared to the CPI, which stands for the Consumer Price
  • You look at the price up there, but now you've only got one, so how much negotiating power does anyone
Summary: The Committee on Public Health convened to discuss various bills related to mental health, public health initiatives, and animal care. Notably, representatives presented House Bill 2264, which aims to facilitate communication between mental health patients and their families, allowing family members to provide important medical information during emergencies. The bill sparked a substantial discussion, with advocates from the National Alliance on Mental Illness supporting its intention to improve patient outcomes. Other significant bills included HB 1747, introduced to create a council for mental health and substance use, fostering collaboration among affected systems, and HB 2684, which focuses on palliative care options for parents facing life-limiting diagnoses for their unborn children. Public testimonies supported these measures, highlighting their importance in enhancing care and support for vulnerable populations.
TX

Texas 2025 - 89th Regular

89th Legislative Session May 29th, 2025 at 02:05 pm

Texas House Floor Meeting

Transcript Highlights:
  • data-time="11664"> He doesn't completely agree with, so they shortened the sunset date for the Texas Pharmaceutical
Summary: The committee meeting included discussions on various bills, notably focusing on school safety funding, social media regulations related to drug selling, and an amendment concerning the Texas Pharmaceutical Initiative. SB260 was a key topic, proposing substantial increases to school safety allotments, which was adopted with overwhelming support. Similarly, the discussion around SB2155 addressed significant changes in the handling of veterinary medical examinations and stirred interest from various stakeholders. Members expressed concern about the impact of drug sales on social media, with a strong emphasis on protecting youth from illicit substances, which led to the adoption of legislative measures to enhance penalties for related offenses. The atmosphere was both tense and collaborative as representatives pushed for necessary changes in legislation.
TX

Texas 2025 - 89th Regular

Health and Human Services (Part II) May 21st, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • " data-time="2916">Members, last session I sponsored House Bill 1490, which created the Texas Pharmaceutical
  • Members, the Texas Pharmaceutical Initiative is really

  • When food prices go down, that's when you can hold your margin
  • The market dictates your prices. If your price is too high, nobody's going to buy it.
Summary: The committee meeting featured extensive discussions surrounding various bills, notably focusing on HB3284, which aims to establish a commission to promote marriage and family stability while addressing the needs of vulnerable children in the Texas foster care system. Witnesses provided diverse perspectives, with some expressing support for the bill's goal of strengthening family units, while others raised concerns about the potential discrimination against single-parent households and LGBTQ+ families. Additional highlights included debates on HB1106 regarding the treatment of transgender youth and HB4638, which sought to streamline the state's engagement with developers and capacity builders, addressing concerns over administrative efficiencies and child welfare.
TX

Texas 2025 - 89th Regular

Health and Human Services (Part I) May 21st, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • that it gets tagged as a drug, but it's just another indication of the stranglehold that the pharmaceutical
  • data-time="7380"> ...the FDA and what's allowed out there because this is not something where the pharmaceutical
Summary: The committee meeting convened to discuss a variety of bills primarily related to healthcare and early childhood education. Notably, the committee reported favorably on several bills including HB721, HB2035, and HB2038, with all receiving unanimous support of 7-0. Senator Perry played a crucial role in moving the bills forward, advocating for their inclusion on the local and uncontested calendars. Furthermore, there was significant discussion surrounding HB3940, which addresses Medicaid eligibility for newborns, emphasizing the necessity for automatic enrollment to avoid gaps in coverage for infants during critical early stages of development. The meeting was characterized by the committee's cohesive efforts to streamline processes and enhance the efficiency of healthcare services for vulnerable populations.
TX

Texas 2025 - 89th Regular

89th Legislative Session May 5th, 2025 at 11:05 am

Texas House Floor Meeting

Transcript Highlights:
  • granted in room E2.010 to consider House Bill 1225 by Gates, relating to the establishment of a bundle pricing
  • While these individuals technically qualify for Medicare plans due to their condition, many are priced
Bills: HJR34, HB113, HB184, HB198, HB247, HB367, HB449, HB1778, HB514, HB576, HB632, HB1395, HB2225, HB2582, HB2494, HB766, HB2715, HB2712, HB3069, HB3505, HB1269, HB4224, HB3609, HB5032, HB2240, HB5180, HB3348, HB4668, HB4909, HB4665, HB4895, HB3395, HB3157, HB4762, HB4395, HB4325, HB4952, HB4386, HB4273, HB2760, HB2697, HB2820, HB1828, HB1768, HB1579, HB1773, HB1871, HB2035, HB2448, HB2492, HB1411, HB4753, HB4666, HB4529, HB1499, HB1610, HB2028, HB1506, HB886, HB3546, HB796, HB223, HB1475, HB3556, HB4638, HCR126, HB38, HB104, SB1008, SB1106, SB1172, SB2629, SB2964, SB616, HB2214, SB552, HB3181, HB3628, HB589, HB3529, HB3354, HB333, HB2914, HB4130, HB4131, HB24, HB1160, HB3962, HB4115, HB2295, HB5398, HB1407, HB3800, HB2613, HJR138, HB42, HJR34, HB129, HB677, HB426, HB668, HB1699, HB2017, HB2128, HB2038, HB3783, HB3717, HB2316, HB3686, HB2563, HB3883, HB4021, HB2788, HB2663, HB3305, HB3173, HB3474, HB1105, HB3531, HB3490, HB3597, HB1295, HB3512, HB3010, HB3112, HB4215, HB3223, HB3464, HB3120, HB4214, HB4511, HB3704, HB4081, HB4783, HB4063, HB2783, HB4937, HB5085, HB2510, HB3426, HB4361, HB1169, HB2516, HB2347, HB4034, HB4700, HB3560, HB5150, HB3860, HB3146, HB3924, HB113, HB184, HB198, HB247, HB367, HB449, HB1778, HB514, HB576, HB632, HB1395, HB2225, HB2582, HB2494, HB766, HB2715, HB2712, HB3069, HB3505, HB1269, HB4224, HB3609, HB5032, HB2240, HB5180, HB3348, HB4668, HB4909, HB4665, HB4895, HB3395, HB3157, HB4762, HB4395, HB4325, HB4952, HB4386, HB4273, HB2760, HB2697, HB2820, HB1828, HB1768, HB1579, HB1773, HB1871, HB2035, HB2448, HB2492, HB1411, HB4753, HB4666, HB4529, HB1499, HB1610, HB2028, HB1506, HB886, HB3546, HB796, HB223, HB1475, HB3556, HB4638, HCR98, HCR92, HCR126
Summary: The meeting of the committee was focused on a diverse range of bills highlighting significant social, technological, and regulatory topics. Notable discussions included House Bill 3783, where Representative Hull emphasized the importance of protecting parents and children from abusive counseling practices in the family court system. The bill passed to engrossment unanimously. Additionally, House Bill 4215 sparked a discussion around the regulation of delivery network companies, emphasizing the need for oversight and accountability within the expanding gig economy. This bill also passed, showcasing bipartisan support for the initiative. The meeting concluded with a commitment to address ongoing legislative concerns while recognizing the role of public input in shaping laws.
TX

Texas 2025 - 89th Regular

Insurance Apr 9th, 2025 at 10:30 am

House Insurance Committee

Transcript Highlights:
  • Does it say the price?
  • We still give 340B pricing to covered entities.
  • The pharmaceuticals are strangling delivery.
  • Number one, they negotiate the drug prices with the manufacturers.
  • There are over 20,000 pharmaceutical manufacturers, so they are negotiating those prices with those manufacturers
Summary: The House Committee on Insurance convened to discuss multiple bills aimed at enhancing consumer protection and improving access to essential services. Notable discussions included HB2528, which seeks to eliminate prior authorization requirements for medications treating substance use disorders, thereby expediting access to crucial treatments for Texans. Representative Boosie laid out HB722, addressing transparency in auto insurance valuation processes, prompting engagement from various witnesses on how current practices potentially exploit consumers. Members voiced concerns about the intersection of bureaucratic delays and the urgency of addiction treatment, emphasizing the bill's potential life-saving implications.
TX
Transcript Highlights:
  • So just know, the markets are where the markets are, and the prices are where the prices are.
  • Oh, and I'm sorry, Grace Price. Is Grace with us? Awesome.
  • pharmaceutical industry.
  • The chair calls up Grace Price.
  • I'm Grace Price, and I...
Summary: The meeting of the Senate Committee on Health and Human Services centered around two significant bills, SB25 and SB314, aimed at addressing the growing health crisis in Texas, particularly concerning children. The legislators acknowledged the prevalence of diet-related chronic health issues, including obesity and diabetes, and emphasized the need for a legislative response to improve dietary standards in schools. Senator Kocher championed SB25, which promotes measures like nutrition training for physicians, enhanced food labeling, and physical activity in schools as ways to combat the health crisis. Senator Hughes presented SB314, focusing specifically on prohibiting certain harmful chemicals in school meal programs and ensuring that children have access to healthier food options during school hours.
TX
Transcript Highlights:
  • Honestly, if you own 3% of a pharmaceutical company, you own a lot of it. We made those changes.
  • Consanguinity is not allowed to maintain an ownership interest in a pharmaceutical food.
  • Honestly, if you own 3% of a pharmaceutical company, you own a lot of it, so.
  • ...you're going to naturally lower prices.
  • So, this will not increase prescription drug prices.
Summary: The meeting involved in-depth discussions focused primarily on several significant bills aimed at reforming healthcare, improving consumer protection, and enhancing community-based care. Key highlights included House Bill 1919 and House Bill 1763, which address the roles and regulation of pharmacy benefit managers (PBMs) in Texas. Lawmakers emphasized the need for these bills to create a fairer landscape for independent pharmacies while ensuring patient access to necessary medications. Public testimonies reflected both support for the reforms and concerns regarding their potential implications. Another major topic was Senate Bill 513, which proposes the development of a pilot program for community-based care in rural West Texas, aiming to improve child welfare services in regions facing unique challenges.
US
Transcript Highlights:
  • In one large study, there was a 50% reduction in death at half the price.
  • They also create a pricing spread, and that's...
  • Yes or no, will you continue to defend Medicare drug pricing negotiation programs?
  • pricing power, device manufacturer pricing power, and consolidation in the industry.
  • We have got to get a fair price.
Summary: The committee convened to discuss critical issues surrounding the nomination of Michael Falkender for the position of Deputy Secretary of the Treasury. This meeting included a series of remarks from committee members who expressed divergent views on Falkender's qualifications and the implications of his appointment. Senator Wyden voiced strong opposition, arguing that Falkender represents harmful policies expected to be perpetuated under the current administration, especially concerning taxpayer privacy and IRS tactics. Meanwhile, other members defended Falkender, noting his extensive experience, including a commitment to transparency in government operations if confirmed.

Research Filters

States
Terms / Sessions
Date Range
Chamber Records
Meetings / Events / Calendars